Cocrystal Pharma, Inc. (COCP) Dividend History

Cocrystal Pharma, Inc. (COCP) is a biotechnology company focused on developing antiviral therapeutics and diagnostics. It leverages its expertise in structure-based drug design and proprietary platforms to create treatments for viral infections such as hepatitis, influenza, and COVID-19. The company's approach combines scientific innovation with targeted antiviral development to address significant unmet medical needs.

19805 N. Creek Parkway, Bothell, WA, 98011
Phone: (786) 459-1831
Website: https://www.cocrystalpharma.com

Dividend History

Cocrystal Pharma, Inc. currently does not pay dividends

Company News

  • Cocrystal Pharma's CFO and co-CEO James Martin will present a company overview at the H.C. Wainwright 27th Annual Global Investment Conference, discussing their clinical-stage antiviral drug development efforts.

    GlobeNewswire Inc.
  • When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?

    Zacks Investment Research
  • Cocrystal Pharma (NASDAQ:COCP) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 2 0 0 0 0 These 4 analysts have an average price target of $12.0 versus the current price of Cocrystal Pharma at $2.9899, implying upside. Below is a summary of how these 4 analysts rated Cocrystal Pharma over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative ...Full story available on Benzinga.com

    Benzinga
  • Penny stocks to watch this week under $3. The post Penny Stocks To Buy Now? 4 Under $3 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: EOSE HCTI QBTS
Page data last updated 09/07/2025 00:18:17 UTC